Results 261 to 270 of about 93,749 (369)
Prevalence of Metabolic‐Associated Steatotic Liver Disease in Patients With Primary Aldosteronism
ABSTRACT Objective To assess the prevalence of metabolic associated steatotic liver disease (MASLD) in patients with primary aldosteronism (PA) compared to benign adrenal adenomas, and to evaluate the impact of hormonal excess in inducing MASLD. Design Single‐centre retrospective study. Methods Hepatic steatosis was assessed by liver/spleen (L/S) ratio
Irene Tizianel+6 more
wiley +1 more source
Clinical Management of Postoperative Growth Hormone Deficiency in Hypothalamic-Pituitary Tumors. [PDF]
Iglesias P.
europepmc +1 more source
Correction to: Imaging of pituitary tumors: an update with the 5th WHO Classifications-part 2. Neoplasms other than PitNET and tumor-mimicking lesions. [PDF]
Tsukamoto T, Miki Y.
europepmc +1 more source
Tumor Necrosis Factor Alpha Differentially Regulates Beta-Endorphin Concentrations and Proopiomelanocortin RNA in the Anterior and Neurointermediate Pituitary in vivo [PDF]
Paola Sacerdote+4 more
openalex +1 more source
ABSTRACT Objective Detecting hypotonic urine (specific gravity < 1005 g/L) is crucial for the early identification of arginine vasopressin deficiency (AVP‐deficiency), a common complication after pituitary surgery. This study aimed to evaluate the agreement between urine specific gravity measurements taken by patients using urine test strips and those ...
Jeanne‐Marie Nollen+7 more
wiley +1 more source
Time taken to resume activities of daily living after transsphenoidal surgery for pituitary tumors. [PDF]
Lee JA+6 more
europepmc +1 more source
ABSTRACT Background In the last two decades, over 250 000 refugees and asylum seekers have arrived in Australia, many of whom experience significant health problems. Information about their eye health is scarce, particularly for those detained offshore. This is the first study to explore the eye health and services available to this population, helping
Marcel M. Nejatian+3 more
wiley +1 more source
Aggressive Pituitary Tumors and Pituitary Carcinomas: From Pathology to Treatment.
Burman P+3 more
europepmc +1 more source